Policy Analysis on Power Seat Elevation Systems.

In the early 2000s the Centers for Medicare and Medicaid Services determined that power seat elevation systems did not meet the definition of durable medical equipment, and therefore are non-covered items. Yet, power seat elevation systems are covered by other funding sources, and many power wheelchair users utilize these systems regularly when performing tasks such as transferring, reaching, and looking at objects in environments designed for ambulatory people. Adjusting for height when performing these tasks may reduce the onset of pain and comorbidities. To improve access to power seat elevation systems, a clinical team of 4 Clinician Task Force members investigated applicable literature, compiled evidence, and evaluated existing policies to explain the medical nature of power seat elevation systems as a part of a greater interprofessional effort. This manuscript aims to analyze Medicare's policy decision that power seat elevation systems are not primarily medical in nature using Bardach's 8-step framework. As a special communication, this will inform health care professionals of the medical nature of power seat elevation systems and the evidence-based conditions under which power wheelchair users may need power seat elevation systems, as well as empower clinicians to engage in policy directives to affect greater change.

Everyday use of power adjustable seat height (PASH) systems.

The objective of this study was to measure how, why, and where the power adjustable seat height (PASH) system of Quantum's iLevel® wheelchairs were used. We instrumented iLevel® power wheelchairs for 24 adults to measure wheelchair occupancy, seat height, in-seat activity level, and bouts of mobility. Participants elevated their wheelchair 3.9 (4.4) (mean (SD)) times per day, including 1.0 (1.6) times per day past 9". Twenty-nine percent of elevation events were transient, lasting < 1 min, while 42% of elevate events lasted >5 minutes. Sixty-seven percent of participants transferred while elevated at least once, typically from heights <5" or >9", and 14 people changed their seat height between the transfer to and from the wheelchair. Twenty-three of 24 participants wheeled while elevated. Finally, in-seat activity level was greater while elevated. For many participants, the PASH system provided a functional benefit on a daily basis. Individuals elevated 4 times per day for activities including transfers, reach, gaze, or mobility. However, 14 participants did not elevate on at least 1 day. Further study is needed to identify the characteristics of people who will benefit most from a PASH system as well as to document the value associated with PASH system use.